Dow Up 0.11% Nasdaq Up 0.50%

ArQule Inc. (ARQL)

-NasdaqGM
1.32 Up 0.03(2.33%) Aug 29, 4:00PM EDT
Prev Close:1.29
Open:1.30
Bid:N/A
Ask:2.60 x 5000
1y Target Est:3.06
Beta:1.25
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:1.28 - 1.32
52wk Range:1.24 - 2.94
Volume:110,548
Avg Vol (3m):506,989
Market Cap:82.86M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARQL

Comparison

Symbol% ChgMkt Cap
ARQLUp 2.33%82.86M
ARRYUp 2.07%520.70M
ASTX 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.11
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.46
Quarterly EPS Est (Sep-14) :-0.13
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.56

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ArQule, Inc., a clinical-stage biotechnology company, researches and develops cancer therapeutics. Its lead product candidate tivantinib is an inhibitor of the c-Met receptor tyrosine kinase and its biological pathway, which is in Phase 3 clinical... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback